NDC 70223-001

Elroselabs

Conzerol

Elroselabs is a Topical Cream in the Human Otc Drug category. It is labeled and distributed by Elroselabs Inc.. The primary component is Potassium Chloride; Sulfur; Potassium Bromide; Silicon Dioxide; Oyster Shell Calcium Carbonate, Crude; Sodium Chloride.

Product ID70223-001_24a80a2a-7953-004d-e054-00144ff8d46c
NDC70223-001
Product TypeHuman Otc Drug
Proprietary NameElroselabs
Generic NameConzerol
Dosage FormCream
Route of AdministrationTOPICAL
Marketing Start Date2015-12-10
Marketing CategoryUNAPPROVED HOMEOPATHIC / UNAPPROVED HOMEOPATHIC
Labeler NameElroselabs Inc.
Substance NamePOTASSIUM CHLORIDE; SULFUR; POTASSIUM BROMIDE; SILICON DIOXIDE; OYSTER SHELL CALCIUM CARBONATE, CRUDE; SODIUM CHLORIDE
Active Ingredient Strength6 [hp_X]/30g; [hp_X]/30g; [hp_X]/30g; [hp_C]/30g; [hp_C]/30g; [hp_X]/30g
NDC Exclude FlagN
Listing Certified Through2019-12-31

Packaging

NDC 70223-001-01

1 g in 1 CARTON (70223-001-01)
Marketing Start Date2016-01-06
NDC Exclude FlagN
Sample Package?N

NDC SPL Data Element Entries

NDC 70223-001-01 [70223000101]

Elroselabs CREAM
Marketing Categoryunapproved homeopathic
Product TypeHUMAN OTC DRUG
Marketing Start Date2016-01-06
Inactivation Date2020-01-31

NDC 70223-001-06 [70223000106]

Elroselabs CREAM
Marketing Categoryunapproved homeopathic
Product TypeHUMAN OTC DRUG
Marketing Start Date2015-11-16
Inactivation Date2020-01-31

Drug Details

Active Ingredients

IngredientStrength
POTASSIUM CHLORIDE6 [hp_X]/30g

OpenFDA Data

SPL SET ID:24a80a2a-7952-004d-e054-00144ff8d46c
Manufacturer
UNII

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.